Literature DB >> 3242793

Trends in cervix cancer mortality.

J Cuzick1, P Boyle.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3242793

Source DB:  PubMed          Journal:  Cancer Surv        ISSN： 0261-2429


× No keyword cloud information.
  10 in total

1.  Increase in cervical cancer mortality in Spain, 1951-1991.

Authors:  J Llorca; M D Prieto; M Delgado-Rodríguez
Journal:  J Epidemiol Community Health       Date:  1999-07       Impact factor: 3.710

2.  Time trends in incidence of cervical cancer in Lithuania from 1983 to 1997.

Authors:  R Didziapetris; M Stukonis; J Kurtinaitis
Journal:  Eur J Epidemiol       Date:  1999-11       Impact factor: 8.082

Review 3.  Screening for cervical cancer: a review of women's attitudes, knowledge, and behaviour.

Authors:  F Fylan
Journal:  Br J Gen Pract       Date:  1998-08       Impact factor: 5.386

4.  Priorities for vaginal microbicide research.

Authors:  D C Sokal; P L Hermonat
Journal:  Am J Public Health       Date:  1995-05       Impact factor: 9.308

5.  The Cuban National Cancer Registry: 1986-1990.

Authors:  A A Martín; Y H Galán; A J Rodríguez; M Graupera; P Lorenzo-Luaces; L M Fernández; R Camacho; M Lezcano
Journal:  Eur J Epidemiol       Date:  1998-04       Impact factor: 8.082

6.  Evidence for cervical cancer mortality with screening program in Taiwan, 1981-2010: age-period-cohort model.

Authors:  Shih-Yung Su; Jing-Yang Huang; Chien-Chang Ho; Yung-Po Liaw
Journal:  BMC Public Health       Date:  2013-01-08       Impact factor: 3.295

7.  Determinants of risk of invasive cervical cancer in young women.

Authors:  F Parazzini; L Chatenoud; C La Vecchia; E Negri; S Franceschi; G Bolis
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

8.  Low risk of cervical cancer during a long period after negative screening in the Netherlands.

Authors:  M E van den Akker-van Marle; M van Ballegooijen; J D F Habbema
Journal:  Br J Cancer       Date:  2003-04-07       Impact factor: 7.640

Review 9.  Maps and atlases of cancer mortality: a review of a useful tool to trigger new questions.

Authors:  Alberto d'Onofrio; Chiara Mazzetta; Chris Robertson; Michel Smans; Peter Boyle; Mathieu Boniol
Journal:  Ecancermedicalscience       Date:  2016-09-01

10.  Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.

Authors:  Markus Hoffmann; Heike Hofmann-Winkler; Joan C Smith; Nadine Krüger; Lambert K Sørensen; Ole S Søgaard; Jørgen Bo Hasselstrøm; Michael Winkler; Tim Hempel; Lluís Raich; Simon Olsson; Takashi Yamazoe; Katsura Yamatsuta; Hirotaka Mizuno; Stephan Ludwig; Frank Noé; Jason M Sheltzer; Mads Kjolby; Stefan Pöhlmann
Journal:  bioRxiv       Date:  2020-08-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.